Analysts had been forecasting weight loss of 20% to 23% based on earlier Phase 2 data, so the 28.7% figure caught many by surprise
Meet the Expert: Howard Krauss, M.D., is a surgical neuro-ophthalmologist and director of Pacific Neuroscience Institutes Eye, Ear & Skull Base Center in Santa Monica, California
These findings have generated interest in whether GLP-1-based therapies might benefit neurodegenerative conditions such as Alzheimer's disease
R01NS109537 to J.L.)
Semaglutide is available as a once-weekly injection (Ozempic and Wegovy) or a daily tablet (Rybelsus)
Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D: The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity